Literature DB >> 1148076

Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.

G G Harrison.   

Abstract

Experiments are described which demonstrate that dantrolene sodium effectively terminates the syndrome of malignant hyperpyrexia induced in susceptible swine by exposure to halothane. Dantrolene is also shown to block initiation of the syndrome of malignant hyperpyrexia by halothane in MHS swine. Therapeutic use of this drug in patients with anaesthetic-induced malignant hyperpyrexia appears to be indicated.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1148076     DOI： 10.1093/bja/47.1.62

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


  38 in total

1.  Preparation of Injectable Dantrolene for Emergency Treatment of Malignant Hyperthermia-like Syndromes.

Authors:  P J O'brien; G W Forsyth
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008

2.  Anesthesiology-epitomes of progress: malignant hyperthermia: an update.

Authors:  K Iwamoto; R C Reynolds
Journal:  West J Med       Date:  1978-02

Review 3.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

4.  Mind the magnesium, in dantrolene suppression of malignant hyperthermia.

Authors:  Stephen C Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-25       Impact factor: 11.205

5.  Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Authors:  Bénédicte Oulès; Dolores Del Prete; Barbara Greco; Xuexin Zhang; Inger Lauritzen; Jean Sevalle; Sebastien Moreno; Patrizia Paterlini-Bréchot; Mohamed Trebak; Frédéric Checler; Fabio Benfenati; Mounia Chami
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

6.  Effects of dantrolene and its derivatives on Ca(2+) release from the sarcoplasmic reticulum of mouse skeletal muscle fibres.

Authors:  T Ikemoto; T Hosoya; H Aoyama; Y Kihara; M Suzuki; M Endo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 7.  Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

8.  Relationship between plasma concentration and effect of dantrolene sodium in man.

Authors:  W J Meyler; H W Mols-Thürkow; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

9.  Dantrolene reduces the threshold and gain for shivering.

Authors:  Chun-Ming Lin; Sharma Neeru; Anthony G Doufas; Edwin Liem; Yunus Muneer Shah; Anupama Wadhwa; Rainer Lenhardt; Andrew Bjorksten; Akiko Taguchi; Barhara Kabon; Daniel I Sessler; Andrea Kurz
Journal:  Anesth Analg       Date:  2004-05       Impact factor: 5.108

10.  Autosomal dominant multicore disease.

Authors:  J A Vanneste; F C Stam
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-04       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.